Cineverse Corp. 10-Q

ITEM 5. OTHER INFORMATION The Company is planning to move its 2025 annual meeting of stockholders (the “2025 Annual Meeting”) ahead by more than 30 days of the date of the 2024 annual meeting of stockholders. The Company will provide details regarding the date, time, location and matters to be voted on at the 2025 Annual Meeting in the Company’s proxy statement for the 2025 Annual Meeting. In accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended (“Rule 14a-8”), and the Amended and Restated Bylaws (the “Bylaws”) of the Company, the deadlines for the receipt of any stockholder proposals and director nominations to be considered at the 2025 Annual Meeting are set forth below. Rule 14a-8 Proposals Deadline. Any stockholder proposals intended for inclusion in the Company’s definitive proxy statement for the 2025 Annual Meeting pursuant to Rule 14a-8 must be received at the Company’s principal executive office on or before August 30, 2025 (which the Company believes is a reasonable time before it begins to print and send its proxy materials). Such proposals also need to comply with the Securities and Exchange Commission stockholder proposal rules. Advance Notice Proposals and Nominations. In addition, any stockholder seeking to nominate a director or to bring other business before the 2025 Annual Meeting outside of Rule 14a-8 under the advance notice provisions included in the Company’s Bylaws must provide timely notice, as set forth in the Bylaws. Specifically, written notice of any such proposed business or nomination must be received by our Secretary at our principal executive offices not earlier than close of business not earlier than the 120th day before prior to the annual meeting, or July 15, 2025, and not later than the close of business on the later of the ninetieth (90th) day prior to such annual meeting or the tenth (10th) day following the date on which public announcement of the date of such meeting is first made, or August 24, 2025. Any notice of proposed business or nomination also must comply with the notice and other requirements set forth in our Bylaws and with any applicable law. ITEM 6. EXHIBITS The exhibits are listed in the Exhibit Index beginning on the following page herein. 29 EXHIBIT INDEX Exhibit Number Description of Document 31.1 Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Officer’s Certificate Pursuant to 15 U.S.C. Section 7241, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.1 Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2 Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 101.INS Inline XBRL Instance Document. 101.SCH Inline XBRL Taxonomy Extension Schema With Embedded Linkbases Document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). 30 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CINEVERSE CORP. Date: August 14, 2025 By: /s/ Christopher J. McGurk Christopher J. McGurk Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) Date: August 14, 2025 By: /s/ Mark Lindsey Mark Lindsey Chief Financial Officer (Principal Financial Officer) 31